Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg (IPEC-EFV)
This study has been terminated.
(Lack of financial support and low inclusion rate)
Sponsor:
Oswaldo Cruz Foundation
Collaborators:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
UNODOC
Information provided by (Responsible Party):
Valeria Cavalcanti Rolla, Oswaldo Cruz Foundation
ClinicalTrials.gov Identifier:
NCT00533390
First received: September 19, 2007
Last updated: December 28, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | October 2012 |
| Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |